GHK-Cu vs AHK-Cu — Why One Methyl Group Changes the Coordination Geometry

Glycyl-L-histidyl-L-lysine (GHK) and alanyl-L-histidyl-L-lysine (AHK) are tripeptides that differ by one methyl group at the N-terminal α-carbon. Each binds Cu(II) tightly enough to be the active form. In their free-peptide states the difference between Gly and Ala is barely consequential. In the Cu(II) complex it is the difference between two molecules with measurably different formation constants, different receptor binding profiles, and — in atelier work — different release-data signatures.

This Note unpacks why the methyl group matters at the metal coordination site, what the geometric difference is, and why a chemistry-led ingredient house treats GHK-Cu and AHK-Cu as separately characterized molecules rather than substitutes.

The shared Cu(II) coordination motif

The Cu(II) coordination chemistry of GHK has been mapped extensively. In the 1:1 Cu(II)·GHK complex at physiological pH, the copper sits at the centre of a roughly square-planar coordination sphere with four ligand atoms:

• The α-amino nitrogen from the N-terminal residue (the Gly)
• The deprotonated amide nitrogen of the Gly-His peptide bond
• The imidazole nitrogen (most commonly the N1 / Nδ tautomer) from the His side chain
• A carboxylate oxygen from the C-terminal Lys, often via a bridge from a neighbouring complex molecule in solid-state

The first three ligands form a chelate ring system within the same peptide molecule. The His imidazole acts as the strongest anchor; the deprotonated amide N is the structural marker of the high-affinity complex (this amide deprotonation has a pKa around 5.5, which is why the complex is fully formed and stable at physiological pH but partially dissociated at lower pH).

This coordination motif is preserved in AHK-Cu — the imidazole-N anchor, the deprotonated amide-N from the (now) Ala-His peptide bond, and the α-amino-N at the N-terminus are all the same conceptual ligands. The difference is what the α-amino-N is attached to.

What the methyl group does

The Gly α-carbon has two hydrogens; the Ala α-carbon has one hydrogen and one methyl. When the α-amino-N coordinates Cu(II), the geometric constraint at that ligand position changes:

• **Gly** — small α-substituent (H) gives the α-amino-N significant rotational freedom; the geometric angle between this N and the other Cu ligands settles close to the energetically preferred square-planar geometry with minimal strain
• **Ala** — methyl α-substituent restricts rotation; the α-amino-N approach to Cu(II) is slightly off the ideal square-planar plane, introducing a small but real distortion in the coordination geometry

The distortion has three measurable consequences:

• **Formation constant** — AHK-Cu has a slightly lower formation constant than GHK-Cu (a small log K difference, on the order of 0.3–0.5 units), reflecting the modest geometric strain
• **d-d band position** — the AHK-Cu d-d transition is shifted ~5–15 nm from GHK-Cu under matched conditions, because the slightly different ligand field around the Cu(II) shifts the d-orbital splitting energy
• **Receptor and target binding** — downstream affinities for cell-surface receptors, transcription factors, and chaperones depend on the exact geometry of the Cu(II) complex; the structural differences between GHK-Cu and AHK-Cu produce different in-vitro and in-vivo activity profiles for hair, scalp, and skin endpoints

Why the differences matter for the ingredient house

If a finished product brief specifies 'copper tripeptide' as an active, the formulator needs to commit to which copper tripeptide before formulation work begins. The two are not interchangeable. The most consequential differences for ingredient houses:

• **Different release specifications.** GHK-Cu and AHK-Cu have different reference UV-Vis traces, different reference Cu²⁺:peptide ratios, different reference ΔE colour signatures. A QC method validated for GHK-Cu will not pass an AHK-Cu lot.
• **Different stability profiles.** The slightly weaker formation constant of AHK-Cu means it is marginally more sensitive to pH drift and to reductive interference in formulation work. The exact margins depend on the carrier chemistry but the qualitative ordering is consistent.
• **Different efficacy data sets.** The published research on GHK-Cu for skin regeneration, anti-aging, and copper delivery is extensive. AHK-Cu has its own (smaller but distinct) literature base, especially in scalp and hair work. A claim based on GHK-Cu literature does not transfer to an AHK-Cu formulation; the literature support has to be re-established.
• **Different regulatory positioning.** Both are cosmetic-grade actives with INCI names (Copper Tripeptide-1 for GHK-Cu; Copper Tripeptide-2 or similar for AHK-Cu depending on jurisdiction). The notifications and ingredient-disclosure obligations apply per molecule, not collectively.

How Cupratec treats GHK-Cu and AHK-Cu in the catalogue

Both molecules ship from Cupratec as separately characterized atelier-scale lots. Each has its own master reference (UV-Vis trace, Cu:peptide ratio target, CIELAB master). Each has its own per-lot release packet that compares the released lot against the molecule-specific master rather than a shared reference. The colour difference between the two is small enough that visual inspection alone is not a reliable discriminator — the ICP copper number plus the UV-Vis trace plus the LC-MS identity are the discriminators, and we run them per lot for both.

For a formulator deciding between the two for a new brief, the typical questions to think through:

• **What endpoint is the product targeting?** GHK-Cu has deeper published literature on skin regeneration and wound healing; AHK-Cu has stronger published association with scalp and hair endpoints. The endpoint usually selects the molecule.
• **What carrier chemistry?** AHK-Cu's slightly weaker formation constant means more attention is needed to keep the active intact in low-pH or reductant-rich carrier formulations.
• **Single active or both?** Some products use both (often at separate functional levels) for combined skin + scalp claims. The atelier supports either as a single-active or paired-active program.

Treating GHK-Cu and AHK-Cu as interchangeable would mean releasing a product whose active is not what the brief specifies. The chemistry forbids the substitution; the characterization data confirms it lot by lot.